Dr. Marshall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
169 Ashley Ave
MSC 213
Charleston, SC 29425Phone+1 843-792-3273Fax+1 843-792-5498- Is this information wrong?
Education & Training
- University of FloridaResidency, Radiation Oncology, 1996 - 2000
- Methodist Health System DallasInternship, Surgery, 1995 - 1996
- University of Texas Southwestern Medical SchoolClass of 1995
- University of FloridaMS, Nuclear Engineering Sciences, Health Physics , 1989 - 1991
- Texas A&M UniversityBS, Nuclear Engineering , Cum Laude, 1985 - 1989
Certifications & Licensure
- SC State Medical License 2004 - 2025
- FL State Medical License 1997 - 2020
- NJ State Medical License 2000 - 2005
- NY State Medical License 2003 - 2005
- GA State Medical License 1997 - 2003
- American Board of Radiology Radiation Oncology
- American Board of Radiology Radiation Oncology Recertification
Awards, Honors, & Recognition
- Focused Practice Recognition in Brachytherapy American Board of Radiology, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer Start of enrollment: 2007 Jan 16
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsLong-Term Outcomes of a Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image Guided Intensity Modulated Radiation Therapy for Localized High-Risk Pros...Shauna McVorran, Thomas Keane, David T Marshall> ;Advances in Radiation Oncology. 2022 Mar 10
- Long-Term Outcomes of a Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image-Guided Intensity-Modulated Radiotherapy for Localized High-Risk Prostate ...S.M. McVorran, David T. Marshall> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
- 6 citationsThe Clinical Cell-Cycle Risk (CCR) score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation The...Jonathan D. Tward, Lauren Lenz, Darl D. Flake, Saradha Rajamani, Carl A. Olsson, Deepak A. Kapoor, Constantine Mantz, Stanley L. Liauw, Tatjana Antic, Neal D. Shore, D...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Oct 3
- Join now to see all
Press Mentions
- Partnership Between VA, Hollings Brings Cancer Clinical Trial Opportunities to VeteransAugust 19th, 2023
Hospital Affiliations
- Ralph H. Johnson Veterans Affairs Medical CenterCharleston, South Carolina
- MUSC Health University Medical CenterCharleston, South Carolina
- Tidelands Waccamaw Community HospitalMurrells Inlet, South Carolina
External Links
- MUSC Radiation Oncologyhttps://medicine.musc.edu/departments/radiation-oncology
- Hollings Cancer Centerhttps://hollingscancercenter.musc.edu/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: